CTRI/2018/06/014642
Recruiting
Phase 2
Evaluation of Therapeutic Efficacy and Safety of coded Unani Drugs PTH-1, PTH-2 and PTH-3 in Asymptomatic Hepatitis B Carriers
DG Central Council for Research in Unani Medicine0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- DG Central Council for Research in Unani Medicine
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Subjects of any Gender aged 20\-60 years
- •2\. HBsAg\-Positive Asymptomatic Cases
- •3\. Viral Load \<20,000 IU/mL
Exclusion Criteria
- •1\. Viral Load: \>20,000 IU/mL
- •2\. Active Hepatitis
- •3\. Patients on Immune Suppressants Therapy
- •4\. History of Severe Systemic Disease
- •5\. H/o of Drug or Alcohol Abuse, Chronic Smokers not willing to abstain from smoking during the study period
- •6\. Subjects with known allergies
- •7\. Receiving any other Investigational Product
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
This study will investigate the anticancer effect and treatment-related safety when focused ultrasound stimuli is given for the pancreatic cancer in patients with unresectable pancreatic cancer who need chemotherapy in a prospective mannerNeoplasmsKCT0006302Seoul National University Hospital60
Completed
Phase 2
A study investigating the efficacy and safety of CNS prophylaxis with R-CHOP and high-dose methotrexate in patients with de novo diffuse large B-cell lymphoma who have high risk for CNS relapse.Diffuse large B-cell lymphomaJPRN-UMIN000013540Department of Hematology and Oncology, Osaka University Graduate School of Medicine100
Not yet recruiting
Phase 4
Microneedling with topical autologous Platelet rich plasma versus intralesional Triamcinolone acetonide in Alopecia AreataCTRI/2021/03/031963Dr Surabhi Dayal
Completed
Not Applicable
The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test)JPRN-UMIN000022129Osaka University Hospital5
Completed
Phase 4
Evaluation of therapeutic efficacy and safety of artesunate-amodiaquine, artemether-lumefantrine and dihydroartemisinine-piperaquine for the treatment of uncomplicated Plasmodium falciparum in Democratic Republic of CongoMalariaInfection - Studies of infection and infectious agentsACTRN12616001423404Ministry of Health534